The latest fusions news

Inovio Pharmaceuticals announced that it has received a $300 million investment from Inovit, an American investment firm that specializes in the development of novel compounds.Inovit will now invest $250 million in Inovios proprietary compounds.Inoviol products, the company claims, are a broad-spectrum drug candidate, and have been used in the treatment of a variety of diseases.The…

Read More